Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases

Biomarker Research

Volumn 2, Issue 1, 2014, Pages

  Yang, Jiyeon ^a   Zhang, Lixiao ^a   Yu, Caijia ^a   Yang, Xiao Feng ^a   Wang, Hong ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammatory diseases; Monocytes

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD16 ANTIGEN; CD40 LIGAND; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CX3CR1; FIBRINOGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CEREBROVASCULAR ACCIDENT; DENDRITIC CELL; HEART LEFT VENTRICLE FAILURE; HUMAN; INFLAMMATORY DISEASE; MACROPHAGE; MONOCYTE; MONOCYTOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

MURINAE;

EID: 85040657852     PISSN: None     EISSN: 20507771     Source Type: Journal    
DOI: 10.1186/2050-7771-2-1     Document Type: Review

References (62)

1. Yasaka T, Mantich NM, Boxer LA, Baehner RL. Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol 1981, 127:1515-1518.
2. Kurihara T, Warr G, Loy J, Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997, 186:1757-1762.
3. Nahrendorf M, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007, 204:3037-3047. 10.1084/jem.20070885.
4. Ingersoll MA, Platt AM, Potteaux S, Randolph GJ. Monocyte trafficking in acute and chronic inflammation. Trends Immunol 2011, 32:470-477. 10.1016/j.it.2011.05.001.
5. Meuret G, Bammert J, Hoffmann G. Kinetics of human monocytopoiesis. Blood 1974, 44:801-816.
6. Afiune Neto A, Mansur Ade P, Avakian SD, Gomes EP, Ramires JA. [Monocytosis is an independent risk marker for coronary artery disease]. Arquivos brasileiros de cardiologia 2006, 86:240-244. S0066-782X2006000300013.
7. Maekawa Y, et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 2002, 39:241-246.
8. Ganda A, et al. Mild Renal Dysfunction and Metabolites Tied to Low HDL Cholesterol Are Associated With Monocytosis and Atherosclerosis. Circulation 2013, 127:988-996. 10.1161/CIRCULATIONAHA.112.000682.
9. Chapman CM, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004, 35:1619-1624. 10.1161/01.STR.0000130857.19423.ad.
10. Tani S, et al. Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment. Am J Cardiol 2009, 104:464-469. 10.1016/j.amjcard.2009.04.009.
11. Hurst NP, Nuki G. Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. Br Med J (Clin Res Ed) 1981, 282:2081-2083.
12. Schechter GP, Wahl LM, Oppenheim JJ. Suppressor monocytes in human disease: a review. Adv Exp Med Biol 1979, 121B:283-298.
13. Clarkson SB, Ory PA. CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes. J Exp Med 1988, 167:408-420.
14. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989, 74:2527-2534.
15. Palframan RT, et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001, 194:1361-1373.
16. Si Y, Tsou CL, Croft K, Charo IF. CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J Clin Investig 120:1192-1203.
17. Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008, 26:421-452. 10.1146/annurev.immunol.26.021607.090326.
18. Barbalat R, Lau L, Locksley RM, Barton GM. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 2009, 10:1200-1207. 10.1038/ni.1792.
19. Audoy-Remus J, et al. Rod-Shaped monocytes patrol the brain vasculature and give rise to perivascular macrophages under the influence of proinflammatory cytokines and angiopoietin-2. J Neurosci 2008, 28:10187-10199. 10.1523/JNEUROSCI.3510-08.2008.
20. Auffray C, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 317:666-670. 10.1126/science.1142883.
21. Randolph GJ. Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis. Curr Opin Lipidol 2008, 19:462-468. 10.1097/MOL.0b013e32830d5f09.
22. Qu C, et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med 2004, 200:1231-124. 10.1084/jem.20032152.
23. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
24. Grip O, Bredberg A, Lindgren S, Henriksson G. Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease. Inflamm Bowel Dis 2007, 13:566-572. 10.1002/ibd.20025.
25. Shantsila E, et al. Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J Thromb Haemost 2011, 9:1056-1066. 10.1111/j.1538-7836.2011.04244.x.
26. Rothe G, et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996, 16:1437-1447.
27. Kashiwagi M, et al. Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. Atherosclerosis 2010, 212:171-176. 10.1016/j.atherosclerosis.2010.05.004.
28. Tsujioka H, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol 2009, 54:130-138. 10.1016/j.jacc.2009.04.021.
29. Rogacev KS, et al. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J 2010, 31:369-376. 10.1093/eurheartj/ehp308.
30. Tanaka M, et al. Surface phenotype analysis of CD16+ monocytes from leukapheresis collections for peripheral blood progenitors. Clin Exp Immunol 1999, 116:57-61.
31. Ancuta P, et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 2003, 197:1701-1707.
32. Ziegler-Heitbrock L, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-80. 10.1182/blood-2010-02-258558.
33. Jones KL, Maguire JJ, Davenport AP. Chemokine receptor CCR5: from AIDS to atherosclerosis. Br J pharmacol 2011, 162:1453-1469. 10.1111/j.1476-5381.2010.01147.x.
34. Xu H, Manivannan A, Crane I, Dawson R, Liversidge J. Critical but divergent roles for CD62L and CD44 in directing blood monocyte trafficking in vivo during inflammation. Blood 2008, 112:1166-1174. 10.1182/blood-2007-06-098327.
35. Cros J, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010, 33:375-386. 10.1016/j.immuni.2010.08.012.
36. Wong KL, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011, 118:e16-e31. 10.1182/blood-2010-12-326355.
37. Sunderkotter C, et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004, 172:4410-4417.
38. Hristov M, Weber C. Differential role of monocyte subsets in atherosclerosis. Thromb Haemost 2011, 106:757-762. 10.1160/TH11-07-0500.
39. Yona S, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
40. Zawada AM, et al. Monocyte heterogeneity in human cardiovascular disease. Immunobiology 2012, 217:1273-1284. 10.1016/j.imbio.2012.07.001.
41. Arnold L, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007, 204:1057-1069. 10.1084/jem.20070075.
42. Saederup N, et al. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PloS one 2010, 5:e13693.
43. Zigmond E, et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 2012, 37:1076-1090. 10.1016/j.immuni.2012.08.026.
44. Rivollier A, He J, Kole A, Valatas V, Kelsall BL. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 2012, 209:139-155. 10.1084/jem.20101387.
45. Jenkins SJ, et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011, 332:1284-1288. 10.1126/science.1204351.
46. Egawa M, et al. Inflammatory Monocytes Recruited to Allergic Skin Acquire an Anti-inflammatory M2 Phenotype via Basophil-Derived Interleukin-4. Immunity 2013, 38(3):570-580. 10.1016/j.immuni.2012.11.014.
47. Zhang D, et al. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Circ Res 2012, 111:37-49. 10.1161/CIRCRESAHA.112.269472.
48. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394:200-203. 10.1038/28204.
49. Tedgui A, Bernard C. Cytokines, immuno-inflammatory response and atherosclerosis. Eur Cytokine Netw 1994, 5:263-270.
50. Hakkinen T, Karkola K, Yla-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Archiv 2000, 437:396-405.
51. Lievens D, et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010, 116:4317-4327. 10.1182/blood-2010-01-261206.
52. Lutgens E, et al. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med 2010, 207:391-404. 10.1084/jem.20091293.
53. Mosig S, et al. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL. FASEB J 2009, 23:866-874. 10.1096/fj.08-118240.
54. Phipps RP. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci U S A 2000, 97:6930-6932.
55. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000, 6:114. 10.1038/72162.
56. Gelderblom M, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009, 40:1849-1857.
57. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010, 87:779-789.
58. Kim E, et al. CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia. Ann Neurol 2012, 71:753-764.
59. King IL, Dickendesher TL, Segal BM. Circulating Ly-6C + myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009, 113:3190-3197.
60. Getts DR, et al. Ly6c + " inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med 2008, 205:2319-2337.
61. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 2007, 38:1345-1353.
62. Gliem M, et al. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol 2012, 71:743-752.